163 related articles for article (PubMed ID: 1761045)
1. The solution structure of a monomeric insulin. A two-dimensional 1H-NMR study of des-(B26-B30)-insulin in combination with distance geometry and restrained molecular dynamics.
Knegtel RM; Boelens R; Ganadu ML; Kaptein R
Eur J Biochem; 1991 Dec; 202(2):447-58. PubMed ID: 1761045
[TBL] [Abstract][Full Text] [Related]
2. Structure and dynamics of des-pentapeptide-insulin in solution: the molten-globule hypothesis.
Hua QX; Kochoyan M; Weiss MA
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2379-83. PubMed ID: 1549601
[TBL] [Abstract][Full Text] [Related]
3. Solution structure of the superactive monomeric des-[Phe(B25)] human insulin mutant: elucidation of the structural basis for the monomerization of des-[Phe(B25)] insulin and the dimerization of native insulin.
Jørgensen AM; Olsen HB; Balschmidt P; Led JJ
J Mol Biol; 1996 Apr; 257(3):684-99. PubMed ID: 8648633
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional solution structure of an insulin dimer. A study of the B9(Asp) mutant of human insulin using nuclear magnetic resonance, distance geometry and restrained molecular dynamics.
Jørgensen AM; Kristensen SM; Led JJ; Balschmidt P
J Mol Biol; 1992 Oct; 227(4):1146-63. PubMed ID: 1433291
[TBL] [Abstract][Full Text] [Related]
5. High resolution 1H-NMR studies of Des-(B26-B30)-insulin; assignment of resonances and properties of aromatic residues.
Hua QX; Chen YJ; Wang CC; Wang DC; Roberts GC
Biochim Biophys Acta; 1989 Feb; 994(2):114-20. PubMed ID: 2642711
[TBL] [Abstract][Full Text] [Related]
6. Comparative 2D NMR studies of human insulin and des-pentapeptide insulin: sequential resonance assignment and implications for protein dynamics and receptor recognition.
Hua QX; Weiss MA
Biochemistry; 1991 Jun; 30(22):5505-15. PubMed ID: 2036420
[TBL] [Abstract][Full Text] [Related]
7. Two-dimensional NMR studies on des-pentapeptide-insulin. Proton resonance assignments and secondary structure analysis.
Boelens R; Ganadu ML; Verheyden P; Kaptein R
Eur J Biochem; 1990 Jul; 191(1):147-53. PubMed ID: 2199196
[TBL] [Abstract][Full Text] [Related]
8. Semisynthetic des-(B27-B30)-insulins with modified B26-tyrosine.
Lenz V; Gattner HG; Sievert D; Wollmer A; Engels M; Höcker H
Biol Chem Hoppe Seyler; 1991 Jul; 372(7):495-504. PubMed ID: 1930732
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the dynamic behavior of monomeric and dimeric insulin shows structural rearrangements in the active monomer.
Zoete V; Meuwly M; Karplus M
J Mol Biol; 2004 Sep; 342(3):913-29. PubMed ID: 15342246
[TBL] [Abstract][Full Text] [Related]
10. Solution structure of an engineered insulin monomer at neutral pH.
Olsen HB; Ludvigsen S; Kaarsholm NC
Biochemistry; 1996 Jul; 35(27):8836-45. PubMed ID: 8688419
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of a monomeric insulin analogue: testing the molten-globule hypothesis.
Hua QX; Ladbury JE; Weiss MA
Biochemistry; 1993 Feb; 32(6):1433-42. PubMed ID: 8431423
[TBL] [Abstract][Full Text] [Related]
12. I222 crystal form of despentapeptide (B26-B30) insulin provides new insights into the properties of monomeric insulin.
Whittingham JL; Youshang Z; Záková L; Dodson EJ; Turkenburg JP; Brange J; Dodson GG
Acta Crystallogr D Biol Crystallogr; 2006 May; 62(Pt 5):505-11. PubMed ID: 16627943
[TBL] [Abstract][Full Text] [Related]
13. Structure of monomeric porcine DesB1-B2 despentapeptide (B26-B30) insulin at 1.65 A resolution.
Diao JS; Wan ZL; Chang WR; Liang DC
Acta Crystallogr D Biol Crystallogr; 1997 Sep; 53(Pt 5):507-12. PubMed ID: 15299880
[TBL] [Abstract][Full Text] [Related]
14. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone.
Leyer S; Gattner HG; Leithäuser M; Brandenburg D; Wollmer A; Höcker H
Int J Pept Protein Res; 1995 Nov; 46(5):397-407. PubMed ID: 8567184
[TBL] [Abstract][Full Text] [Related]
15. Two-dimensional NMR studies of Des-(B26-B30)-insulin: sequence-specific resonance assignments and effects of solvent composition.
Hua QX; Weiss MA
Biochim Biophys Acta; 1991 May; 1078(1):101-10. PubMed ID: 1646635
[TBL] [Abstract][Full Text] [Related]
16. Solution structures of the R6 human insulin hexamer,
Chang X; Jorgensen AM; Bardrum P; Led JJ
Biochemistry; 1997 Aug; 36(31):9409-22. PubMed ID: 9235985
[TBL] [Abstract][Full Text] [Related]
17. The high-resolution structure of the histidine-containing phosphocarrier protein HPr from Escherichia coli determined by restrained molecular dynamics from nuclear magnetic resonance nuclear Overhauser effect data.
van Nuland NA; Hangyi IW; van Schaik RC; Berendsen HJ; van Gunsteren WF; Scheek RM; Robillard GT
J Mol Biol; 1994 Apr; 237(5):544-59. PubMed ID: 8158637
[TBL] [Abstract][Full Text] [Related]
18. Structure-function relationships of des-(B26-B30)-insulin.
Spoden M; Gattner HG; Zahn H; Brandenburg D
Int J Pept Protein Res; 1995; 46(3-4):221-7. PubMed ID: 8537175
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional structure of potato carboxypeptidase inhibitor in solution. A study using nuclear magnetic resonance, distance geometry, and restrained molecular dynamics.
Clore GM; Gronenborn AM; Nilges M; Ryan CA
Biochemistry; 1987 Dec; 26(24):8012-23. PubMed ID: 3427120
[TBL] [Abstract][Full Text] [Related]
20. In vivo metabolic activity of des-(B26-B30)-insulin-B25-amide and related analogues in the rat.
Stümpel F; Hartmann H; Brandenburg D; Creutzfeldt W
Diabetes Res Clin Pract; 1990 Jul; 9(3):257-64. PubMed ID: 2226126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
